nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—CALM2—ear—ocular cancer	0.00528	0.141	CbGeAlD
Phenoxybenzamine—CALM1—ear—ocular cancer	0.00526	0.141	CbGeAlD
Phenoxybenzamine—CALM2—pineal body—ocular cancer	0.00458	0.122	CbGeAlD
Phenoxybenzamine—CALM1—pineal body—ocular cancer	0.00456	0.122	CbGeAlD
Phenoxybenzamine—ADRA1D—epithelium—ocular cancer	0.00208	0.0555	CbGeAlD
Phenoxybenzamine—CALM3—eye—ocular cancer	0.00177	0.0473	CbGeAlD
Phenoxybenzamine—CALM3—retina—ocular cancer	0.00175	0.0469	CbGeAlD
Phenoxybenzamine—CALM2—eye—ocular cancer	0.00139	0.0372	CbGeAlD
Phenoxybenzamine—CALM1—eye—ocular cancer	0.00138	0.037	CbGeAlD
Phenoxybenzamine—CALM2—retina—ocular cancer	0.00138	0.0368	CbGeAlD
Phenoxybenzamine—CALM1—retina—ocular cancer	0.00137	0.0367	CbGeAlD
Phenoxybenzamine—CALM2—epithelium—ocular cancer	0.00127	0.034	CbGeAlD
Phenoxybenzamine—CALM1—epithelium—ocular cancer	0.00127	0.0338	CbGeAlD
Phenoxybenzamine—ADRA1A—epithelium—ocular cancer	0.00119	0.0319	CbGeAlD
Phenoxybenzamine—CALM2—lymphoid tissue—ocular cancer	0.000979	0.0262	CbGeAlD
Phenoxybenzamine—CALM1—lymphoid tissue—ocular cancer	0.000974	0.0261	CbGeAlD
Phenoxybenzamine—ADRA1A—lymphoid tissue—ocular cancer	0.000918	0.0246	CbGeAlD
Phenoxybenzamine—CALM3—Signaling Pathways—GNAQ—ocular cancer	0.000306	0.000318	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—HDAC1—ocular cancer	0.000302	0.000314	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—E2F1—ocular cancer	0.000302	0.000313	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—HRAS—ocular cancer	0.0003	0.000311	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by NGF—AKT1—ocular cancer	0.000299	0.000311	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by NGF—AKT1—ocular cancer	0.000299	0.000311	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—CDKN1A—ocular cancer	0.000297	0.000309	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—CDKN1A—ocular cancer	0.000297	0.000309	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—GNAQ—ocular cancer	0.000296	0.000308	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—GNAQ—ocular cancer	0.000296	0.000308	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—CDKN1A—ocular cancer	0.000295	0.000306	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—EP300—ocular cancer	0.000292	0.000304	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CDKN2B—ocular cancer	0.000292	0.000303	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—EP300—ocular cancer	0.000291	0.000302	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—CDKN1A—ocular cancer	0.000285	0.000296	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—CDKN1A—ocular cancer	0.000285	0.000296	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by Wnt—AKT1—ocular cancer	0.000285	0.000296	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Hemostasis—AKT1—ocular cancer	0.000283	0.000294	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—EP300—ocular cancer	0.000283	0.000294	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—EP300—ocular cancer	0.000283	0.000294	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—TGFB1—ocular cancer	0.000282	0.000293	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—HDAC1—ocular cancer	0.000276	0.000287	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by Wnt—AKT1—ocular cancer	0.000276	0.000286	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by Wnt—AKT1—ocular cancer	0.000276	0.000286	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—TGFB1—ocular cancer	0.000273	0.000283	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—TGFB1—ocular cancer	0.000273	0.000283	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CDKN2B—ocular cancer	0.000271	0.000282	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—E2F1—ocular cancer	0.000268	0.000278	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—HDAC1—ocular cancer	0.000267	0.000277	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—HDAC1—ocular cancer	0.000267	0.000277	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—AKT1—ocular cancer	0.000265	0.000275	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—TP53—ocular cancer	0.000255	0.000264	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—E2F1—ocular cancer	0.000249	0.000259	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CDKN2B—ocular cancer	0.000247	0.000257	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—HRAS—ocular cancer	0.000243	0.000253	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CDKN2B—ocular cancer	0.000239	0.000249	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CDKN2B—ocular cancer	0.000239	0.000249	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—TP53—ocular cancer	0.000232	0.000241	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—E2F1—ocular cancer	0.000227	0.000236	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—TP53—ocular cancer	0.000225	0.000233	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—TP53—ocular cancer	0.000225	0.000233	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—HRAS—ocular cancer	0.000222	0.000231	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—E2F1—ocular cancer	0.00022	0.000228	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—E2F1—ocular cancer	0.00022	0.000228	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MDM2—ocular cancer	0.00022	0.000228	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—AKT1—ocular cancer	0.000215	0.000223	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—HRAS—ocular cancer	0.000215	0.000223	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—HRAS—ocular cancer	0.000215	0.000223	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—MDM2—ocular cancer	0.000212	0.00022	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—MDM2—ocular cancer	0.000205	0.000213	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—MDM2—ocular cancer	0.000205	0.000213	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—HRAS—ocular cancer	0.000204	0.000212	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CDKN1B—ocular cancer	0.0002	0.000208	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—HRAS—ocular cancer	0.0002	0.000208	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—AKT1—ocular cancer	0.000198	0.000206	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MDM2—ocular cancer	0.000198	0.000206	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—AKT1—ocular cancer	0.000196	0.000204	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MDM2—ocular cancer	0.000196	0.000204	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MDM2—ocular cancer	0.000196	0.000203	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CDKN1B—ocular cancer	0.000194	0.000201	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—HRAS—ocular cancer	0.000193	0.000201	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—HRAS—ocular cancer	0.000193	0.000201	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—HRAS—ocular cancer	0.000192	0.000199	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CCND1—ocular cancer	0.000191	0.000199	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—AKT1—ocular cancer	0.00019	0.000197	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—AKT1—ocular cancer	0.00019	0.000197	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MDM2—ocular cancer	0.00019	0.000197	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MDM2—ocular cancer	0.00019	0.000197	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CDKN1B—ocular cancer	0.000187	0.000195	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CDKN1B—ocular cancer	0.000187	0.000195	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—HRAS—ocular cancer	0.000186	0.000193	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—HRAS—ocular cancer	0.000186	0.000193	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MDM2—ocular cancer	0.000185	0.000192	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CDKN1A—ocular cancer	0.000185	0.000192	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—HRAS—ocular cancer	0.000184	0.000191	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GNA11—ocular cancer	0.000184	0.000191	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—EP300—ocular cancer	0.000183	0.00019	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MDM2—ocular cancer	0.000182	0.000189	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—HRAS—ocular cancer	0.000182	0.000189	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CDKN1B—ocular cancer	0.000181	0.000188	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—AKT1—ocular cancer	0.00018	0.000187	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—AKT1—ocular cancer	0.000179	0.000186	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CDKN1B—ocular cancer	0.000179	0.000186	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CDKN1A—ocular cancer	0.000179	0.000186	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CDKN1B—ocular cancer	0.000179	0.000186	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—EP300—ocular cancer	0.000178	0.000184	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—AKT1—ocular cancer	0.000177	0.000184	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—AKT1—ocular cancer	0.000177	0.000183	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—EP300—ocular cancer	0.000176	0.000183	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—AKT1—ocular cancer	0.000176	0.000183	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CDKN1B—ocular cancer	0.000173	0.00018	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CDKN1B—ocular cancer	0.000173	0.00018	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CDKN1A—ocular cancer	0.000173	0.00018	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CDKN1A—ocular cancer	0.000173	0.00018	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CCND1—ocular cancer	0.000173	0.000179	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—HRAS—ocular cancer	0.000172	0.000179	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000171	0.000178	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—AKT1—ocular cancer	0.000171	0.000177	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—AKT1—ocular cancer	0.000171	0.000177	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CCND1—ocular cancer	0.00017	0.000177	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—EP300—ocular cancer	0.00017	0.000177	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—EP300—ocular cancer	0.00017	0.000177	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—AKT1—ocular cancer	0.00017	0.000176	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—HRAS—ocular cancer	0.000169	0.000176	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CDKN1B—ocular cancer	0.000169	0.000176	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—AKT1—ocular cancer	0.000167	0.000174	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CDKN1A—ocular cancer	0.000167	0.000174	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CDKN1B—ocular cancer	0.000166	0.000173	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CDKN1A—ocular cancer	0.000165	0.000172	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CDKN1A—ocular cancer	0.000165	0.000171	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—EP300—ocular cancer	0.000165	0.000171	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—EP300—ocular cancer	0.000165	0.000171	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—AKT1—ocular cancer	0.000165	0.000171	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—AKT1—ocular cancer	0.000164	0.00017	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—AKT1—ocular cancer	0.000164	0.00017	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—AKT1—ocular cancer	0.000163	0.000169	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MDM2—ocular cancer	0.000162	0.000168	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CCND1—ocular cancer	0.000161	0.000168	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—AKT1—ocular cancer	0.000161	0.000167	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CDKN1A—ocular cancer	0.00016	0.000166	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CDKN1A—ocular cancer	0.00016	0.000166	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—EP300—ocular cancer	0.000159	0.000165	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CCND1—ocular cancer	0.000159	0.000165	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—EP300—ocular cancer	0.000157	0.000163	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—EP300—ocular cancer	0.000157	0.000163	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CDKN1A—ocular cancer	0.000156	0.000162	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CDKN1A—ocular cancer	0.000154	0.00016	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MYC—ocular cancer	0.000153	0.000159	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TGFB1—ocular cancer	0.000153	0.000159	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—EP300—ocular cancer	0.000152	0.000158	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—EP300—ocular cancer	0.000152	0.000158	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—AKT1—ocular cancer	0.000152	0.000158	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MDM2—ocular cancer	0.00015	0.000156	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—HRAS—ocular cancer	0.00015	0.000156	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—AKT1—ocular cancer	0.000149	0.000155	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—EP300—ocular cancer	0.000148	0.000154	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CDKN1B—ocular cancer	0.000148	0.000154	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—AKT1—ocular cancer	0.000146	0.000152	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—EP300—ocular cancer	0.000146	0.000152	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—EP300—ocular cancer	0.000144	0.00015	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CCND1—ocular cancer	0.000141	0.000146	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—HRAS—ocular cancer	0.00014	0.000145	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MYC—ocular cancer	0.000138	0.000144	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TGFB1—ocular cancer	0.000138	0.000144	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CDKN1B—ocular cancer	0.000137	0.000143	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MDM2—ocular cancer	0.000137	0.000143	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MYC—ocular cancer	0.000137	0.000142	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MYC—ocular cancer	0.000137	0.000142	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—TGFB1—ocular cancer	0.000137	0.000142	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TGFB1—ocular cancer	0.000136	0.000142	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CDKN1A—ocular cancer	0.000136	0.000142	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—AKT1—ocular cancer	0.000136	0.000141	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—AKT1—ocular cancer	0.000133	0.000138	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MDM2—ocular cancer	0.000133	0.000138	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MDM2—ocular cancer	0.000133	0.000138	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MYC—ocular cancer	0.000132	0.000138	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MYC—ocular cancer	0.000132	0.000138	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—TGFB1—ocular cancer	0.000132	0.000137	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—TGFB1—ocular cancer	0.000132	0.000137	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—EP300—ocular cancer	0.000132	0.000137	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCND1—ocular cancer	0.000131	0.000136	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—EP300—ocular cancer	0.00013	0.000135	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MYC—ocular cancer	0.000129	0.000134	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TGFB1—ocular cancer	0.000129	0.000134	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—HRAS—ocular cancer	0.000127	0.000132	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MYC—ocular cancer	0.000127	0.000132	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—EP300—ocular cancer	0.000127	0.000132	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—EP300—ocular cancer	0.000127	0.000132	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TGFB1—ocular cancer	0.000127	0.000132	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CDKN1A—ocular cancer	0.000127	0.000132	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TP53—ocular cancer	0.000126	0.000131	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CDKN1B—ocular cancer	0.000125	0.00013	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—AKT1—ocular cancer	0.000123	0.000128	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—HRAS—ocular cancer	0.000123	0.000128	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—HRAS—ocular cancer	0.000123	0.000128	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CDKN1B—ocular cancer	0.000121	0.000126	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CDKN1B—ocular cancer	0.000121	0.000126	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—EP300—ocular cancer	0.000121	0.000125	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—HRAS—ocular cancer	0.00012	0.000125	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCND1—ocular cancer	0.00012	0.000124	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HRAS—ocular cancer	0.000116	0.000121	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CDKN1A—ocular cancer	0.000116	0.00012	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCND1—ocular cancer	0.000116	0.00012	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCND1—ocular cancer	0.000116	0.00012	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TP53—ocular cancer	0.000114	0.000118	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MYC—ocular cancer	0.000113	0.000117	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TGFB1—ocular cancer	0.000113	0.000117	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HRAS—ocular cancer	0.000113	0.000117	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HRAS—ocular cancer	0.000113	0.000117	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—AKT1—ocular cancer	0.000113	0.000117	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TP53—ocular cancer	0.000112	0.000117	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CDKN1A—ocular cancer	0.000112	0.000116	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CDKN1A—ocular cancer	0.000112	0.000116	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—AKT1—ocular cancer	0.00011	0.000115	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—EP300—ocular cancer	0.00011	0.000114	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—AKT1—ocular cancer	0.000109	0.000113	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—AKT1—ocular cancer	0.000109	0.000113	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—HRAS—ocular cancer	0.000109	0.000113	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—HRAS—ocular cancer	0.000108	0.000112	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—HRAS—ocular cancer	0.000107	0.000112	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—AKT1—ocular cancer	0.000107	0.000111	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—EP300—ocular cancer	0.000106	0.000111	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—EP300—ocular cancer	0.000106	0.000111	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—AKT1—ocular cancer	0.000106	0.000111	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TP53—ocular cancer	0.000106	0.00011	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MYC—ocular cancer	0.000105	0.000109	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TGFB1—ocular cancer	0.000105	0.000109	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TP53—ocular cancer	0.000105	0.000109	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—HRAS—ocular cancer	0.000104	0.000108	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—HRAS—ocular cancer	0.000104	0.000108	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—AKT1—ocular cancer	0.000103	0.000107	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—AKT1—ocular cancer	0.000103	0.000107	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—HRAS—ocular cancer	0.000102	0.000106	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—HRAS—ocular cancer	0.0001	0.000104	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—AKT1—ocular cancer	9.95e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—AKT1—ocular cancer	9.95e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—AKT1—ocular cancer	9.6e-05	9.98e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MYC—ocular cancer	9.59e-05	9.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TGFB1—ocular cancer	9.56e-05	9.94e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—AKT1—ocular cancer	9.49e-05	9.86e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—AKT1—ocular cancer	9.48e-05	9.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TP53—ocular cancer	9.29e-05	9.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MYC—ocular cancer	9.27e-05	9.63e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MYC—ocular cancer	9.27e-05	9.63e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TGFB1—ocular cancer	9.25e-05	9.61e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TGFB1—ocular cancer	9.25e-05	9.61e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—AKT1—ocular cancer	9.18e-05	9.54e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—AKT1—ocular cancer	9.18e-05	9.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—AKT1—ocular cancer	8.97e-05	9.32e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—HRAS—ocular cancer	8.88e-05	9.23e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—AKT1—ocular cancer	8.83e-05	9.17e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—AKT1—ocular cancer	8.71e-05	9.05e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TP53—ocular cancer	8.63e-05	8.96e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—HRAS—ocular cancer	8.25e-05	8.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—AKT1—ocular cancer	7.95e-05	8.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TP53—ocular cancer	7.87e-05	8.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—AKT1—ocular cancer	7.84e-05	8.15e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—AKT1—ocular cancer	7.69e-05	7.99e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—AKT1—ocular cancer	7.69e-05	7.99e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TP53—ocular cancer	7.62e-05	7.91e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TP53—ocular cancer	7.62e-05	7.91e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—HRAS—ocular cancer	7.53e-05	7.82e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—AKT1—ocular cancer	7.29e-05	7.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—HRAS—ocular cancer	7.28e-05	7.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—HRAS—ocular cancer	7.28e-05	7.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—AKT1—ocular cancer	6.65e-05	6.91e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—AKT1—ocular cancer	6.43e-05	6.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—AKT1—ocular cancer	6.43e-05	6.68e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—EP300—ocular cancer	6.14e-05	6.38e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AKT1—ocular cancer	3.71e-05	3.86e-05	CbGpPWpGaD
